On April 2, 2014, J. Martin Carroll and Robert N. Wilson notified VIVUS, Inc. (NASDAQ:VVUS) or the Company, that they will not stand for re-election to the Company’s Board of Directors, or the Board, at the next annual meeting of stockholders. VIVUS, Inc. (NASDAQ:VVUS) shares after opening at $5.00 moved to $5.03 on last trade day and at the end of the day closed at $4.91. Company price to sales ratio in past twelve months was calculated as 6.25 and price to cash ratio as 1.48. VIVUS, Inc. (NASDAQ:VVUS) showed a negative weekly performance of -15.34%.
Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) announces issue of ordinary shares to carry out its business proceeds. The firm has decided to issue 59.17 million ordinary shares for a consideration of a $16.38 million. The amount generated will be used to carry out the research programs. It will also fulfill the need of working capital and will support the current clinical development. Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) shares fell -7.51% in last trading session and ended the day on $1.97. PRAN return on equity ratio is recorded as -143.90% and its return on assets is -114.00%. Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) yearly performance is -12.44%.
NewLead Holdings Ltd (NASDAQ:NEWL) announced on 8 April that it has previously signed a term sheet with a leading financial institution to provide 75% debt financing for two second-hand Panamax vessels for a total of $35 million. NewLead Holdings Ltd (NASDAQ:NEWL) shares moved down -15.41% in last trading session and was closed at $0.560, while trading in range of $0.50 – $0.72. NewLead Holdings Ltd (NASDAQ:NEWL) year to date (YTD) performance is -96.84%.
Honda (NYSE:HMC) reported new-car sales in China declined 2% YoY in March to 59,915 vehicles, mainly due to weak sales of its Accord sedan, Nikkei reports. Honda Motor Co Ltd (ADR) (NYSE:HMC) weekly performance is -6.38%. On last trading day company shares ended up $33.32. Honda Motor Co Ltd (ADR) (NYSE:HMC) distance from 50-day simple moving average (SMA50) is -7.47%. Analysts mean target price for the company is $50.01.
Leave a Reply